Searching the Register
The Register includes the following information for each company: company’s name, address, country of origin, contact details, number of employees, company’s creation date and its general field of activity. It also include information about its product portfolio and development stage. Specific information about individual products is not included in the database.
Please note that selecting more than one field finds companies matching all fields selected (AND-relation).
|
FIELD AND COUNTRY
|
|
|
Company Name |
|
|
|
Field of Activity |
|
|
|
Country |
|
COMPANY SECTOR |
|
(Bio) Pharmaceutical |
|
|
|
|
Early manufacturing/Research&Discovery stage |
|
|
|
Development stage |
|
|
|
Commercialisation/Marketing stage (EU/Non-EU) |
|
|
Medical Device and Technology |
|
|
|
|
Development stage |
|
|
|
Commercialisation/Marketing stage (EU/Non-EU) |
|
PRODUCT INFORMATION |
|
Medicinal Products |
|
|
|
Vaccines |
|
|
|
Therapeutic medicines |
|
|
|
Diagnostic and imaging products |
|
|
|
Combined medicinal products and devices |
|
|
Product Development Stages |
|
|
|
Research/Discovery |
|
|
|
Pharmaceutical development |
|
|
|
Preclinical |
|
|
|
Clinical exploratory |
|
|
|
Clinical confirmatory |
|
|
|
(Pre)registration (EU/Non-EU) |
|
|
|
Marketing (EU/Non-EU) |
|
SUBSTANCES |
|
Chemicals |
|
|
|
|
Single entities |
|
|
|
Combinations of single entities |
|
|
|
Peptides (chemically synthesised) |
|
|
Biologically derived proteins and peptides |
|
|
|
|
Monoclonal antibodies |
|
|
|
Recombinant proteins |
|
|
|
Extracted proteins |
|
|
Nucleic acids (chemically synthesised) |
|
|
|
RNA |
|
|
|
DNA |
|
|
Polymers (natural and synthetic - excluding peptides, proteins and nucleic acids) |
|
|
|
Homopolymers |
|
|
|
Copolymers |
|
|
Advanced therapy medicinal products (in accordance with Regulation EC/1394/2007) |
|
|
|
Somatic cell therapy products |
|
|
|
Tissue engineered products |
|
|
|
Gene therapy products |
|
|
Radionuclides |
|
|
|
Allergens |
|
|
|
Polyclonal immunoglobulins |
|
|
|
Herbal derived complex substances |
|
|
|
Animal derived complex substances |
|
|
SPECIFIC PRODUCT CATEGORIES |
|
|
Biodefense |
|
|
|
Biosimilars |
|
|
|
Excipients |
|
|
|
Foods (functional foods, nutraceuticals) |
|
|
|
Generics |
|
|
|
Genetically modified organisms (GMOs) |
|
|
|
Homeopathics |
|
|
|
New formulations/delivery methods |
|
|
|
Transgenic technology |
|
|
|
Paediatric medicines |
|
|
|
Orphan medicines (in accordance with Orphan Drug Regulation EC/141/2000) |
|
|
|
MUMS (Minor use/Minor species) /Limited market (Veterinary products) |
|
|
|
Maximum residue limits (Veterinary products) |
|
|
|
Medicines for tropical diseases |
|
|
|
Stem cells |
|
|
|
Theranostics (personalised/targeted products, biomarkers, (pharmaco)genomics) |
|
|
|
Nanotechnology (including microparticles, liposomes, microbeads) |
|
|
|
OTC/Non prescription /Self medication |
|
|
|
Medical devices |
|
THERAPEUTIC AREA (assigned or expected ATC codes) |
|
|
A Alimentary tract and metabolism |
|
|
|
B Blood and blood forming organs |
|
|
|
C Cardiovascular system |
|
|
|
D Dermatologicals |
|
|
|
G Genito-urinary system and sex hormones |
|
|
|
H Systemic hormonal preparations, excluding sex hormones |
|
|
|
J General anti-infectives for systemic use |
|
|
|
L Anti-neoplastic and immunomodulating agents |
|
|
|
M Musculo-skeletal system |
|
|
|
N Nervous system |
|
|
|
P Anti-parasitic products, Insecticides, Repellents |
|
|
|
R Respiratory system |
|
|
|
S Sensory organs |
|
|
|
V Various |
|
|
|
|
|